XSHE300957
Market cap2.37bUSD
Jan 16, Last price
41.32CNY
1D
0.93%
1Q
-21.62%
IPO
-76.52%
Name
Yunnan Botanee Bio-Technology Group Co Ltd
Chart & Performance
P/E
22.94
P/S
3.14
EPS
1.80
Div Yield, %
0.00%
Shrs. gr., 5y
3.19%
Rev. gr., 5y
34.80%
Revenues
5.52b
+10.14%
Net income
757m
-28.02%
CFO
610m
-20.67%
Dividend
Jun 11, 20240.60048 CNY/sh
Earnings
May 22, 2025
Profile
Yunnan Botanee Bio-Technology Group Co.LTD manufactures and sells skincare products in China. Its products type cover cleansers and makeup removers, face masks, toners, serums, moisturizers and creams, eye cream, sprays, sun care, foundations, and body cares. The company was founded in 2010 and is based in Kunming, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 5,522,168 10.14% | 5,013,874 24.65% | |||||
Cost of revenue | 4,108,728 | 3,698,278 | |||||
Unusual Expense (Income) | |||||||
NOPBT | 1,413,441 | 1,315,596 | |||||
NOPBT Margin | 25.60% | 26.24% | |||||
Operating Taxes | 109,607 | 163,448 | |||||
Tax Rate | 7.75% | 12.42% | |||||
NOPAT | 1,303,834 | 1,152,148 | |||||
Net income | 756,795 -28.02% | 1,051,332 21.83% | |||||
Dividends | (55,460) | ||||||
Dividend yield | 0.09% | ||||||
Proceeds from repurchase of equity | (109,838) | ||||||
BB yield | 0.38% | ||||||
| Debt | |||||||
Debt current | 103,817 | 62,416 | |||||
Long-term debt | 131,267 | 101,891 | |||||
Deferred revenue | 82,863 | 55,575 | |||||
Other long-term liabilities | 91,463 | 10,500 | |||||
Net debt | (3,703,198) | (3,783,625) | |||||
| Cash flow | |||||||
Cash from operating activities | 610,439 | 769,446 | |||||
CAPEX | (274,275) | ||||||
Cash from investing activities | |||||||
Cash from financing activities | (458,470) | ||||||
FCF | 1,169,600 | 1,639,499 | |||||
| Balance | |||||||
Cash | 3,639,817 | 3,947,931 | |||||
Long term investments | 298,465 | ||||||
Excess cash | 3,662,173 | 3,697,238 | |||||
Stockholders' equity | 3,279,651 | 2,755,771 | |||||
Invested Capital | 2,999,429 | 2,906,030 | |||||
ROIC | 44.16% | 45.28% | |||||
ROCE | 22.37% | 23.20% | |||||
| EV | |||||||
Common stock shares outstanding | 422,791 | 423,600 | |||||
Price | 68.17 -54.32% | 149.24 -22.38% | |||||
Market cap | 28,821,629 -54.41% | 63,218,066 -22.38% | |||||
EV | 25,273,254 | 59,483,944 | |||||
EBITDA | 1,551,334 | 1,408,422 | |||||
EV/EBITDA | 16.29 | 42.23 | |||||
Interest | 4,967 | 4,753 | |||||
Interest/NOPBT | 0.35% | 0.36% | |||||